267 related articles for article (PubMed ID: 25720605)
1. 3,4',5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potency.
Aldawsari FS; Velázquez-Martínez CA
Invest New Drugs; 2015 Jun; 33(3):775-86. PubMed ID: 25720605
[TBL] [Abstract][Full Text] [Related]
2. Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action.
Scherzberg MC; Kiehl A; Zivkovic A; Stark H; Stein J; Fürst R; Steinhilber D; Ulrich-Rückert S
Toxicol Appl Pharmacol; 2015 Aug; 287(1):67-76. PubMed ID: 26044878
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol and resveratrol analogues--structure-activity relationship.
Szekeres T; Fritzer-Szekeres M; Saiko P; Jäger W
Pharm Res; 2010 Jun; 27(6):1042-8. PubMed ID: 20232118
[TBL] [Abstract][Full Text] [Related]
4. 3,4,4'-Trihydroxy-trans-stilbene, an analogue of resveratrol, is a potent antioxidant and cytotoxic agent.
Cai W; Zhang L; Song Y; Zhang B; Cui X; Hu G; Fang J
Free Radic Res; 2011 Nov; 45(11-12):1379-87. PubMed ID: 21974738
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency.
Androutsopoulos VP; Ruparelia KC; Papakyriakou A; Filippakis H; Tsatsakis AM; Spandidos DA
Eur J Med Chem; 2011 Jun; 46(6):2586-95. PubMed ID: 21497957
[TBL] [Abstract][Full Text] [Related]
7. The effect of resveratrol, its naturally occurring derivatives and tannic acid on the induction of cell cycle arrest and apoptosis in rat C6 and human T98G glioma cell lines.
Zielińska-Przyjemska M; Kaczmarek M; Krajka-Kuźniak V; Łuczak M; Baer-Dubowska W
Toxicol In Vitro; 2017 Sep; 43():69-75. PubMed ID: 28595835
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of 3,5,4'-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice.
Pan MH; Gao JH; Lai CS; Wang YJ; Chen WM; Lo CY; Wang M; Dushenkov S; Ho CT
Mol Carcinog; 2008 Mar; 47(3):184-96. PubMed ID: 18085528
[TBL] [Abstract][Full Text] [Related]
9. Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma.
Guo W; Li A; Jia Z; Yuan Y; Dai H; Li H
Eur J Pharmacol; 2013 Oct; 718(1-3):41-7. PubMed ID: 24070814
[TBL] [Abstract][Full Text] [Related]
10. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3.
Hsieh TC; Wong C; John Bennett D; Wu JM
Int J Cancer; 2011 Dec; 129(11):2732-43. PubMed ID: 21225623
[TBL] [Abstract][Full Text] [Related]
11. Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein.
Li S; Zhang W; Yang Y; Ma T; Guo J; Wang S; Yu W; Kong L
Eur J Med Chem; 2016 Nov; 124():1006-1018. PubMed ID: 27783972
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol derivative, trans-3,5,4'-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation.
Alex D; Leong EC; Zhang ZJ; Yan GT; Cheng SH; Leong CW; Li ZH; Lam KH; Chan SW; Lee SM
J Cell Biochem; 2010 Feb; 109(2):339-46. PubMed ID: 20014068
[TBL] [Abstract][Full Text] [Related]
13. Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism.
Simoni D; Roberti M; Invidiata FP; Aiello E; Aiello S; Marchetti P; Baruchello R; Eleopra M; Di Cristina A; Grimaudo S; Gebbia N; Crosta L; Dieli F; Tolomeo M
Bioorg Med Chem Lett; 2006 Jun; 16(12):3245-8. PubMed ID: 16580204
[TBL] [Abstract][Full Text] [Related]
14. Pterostilbene: Mechanisms of its action as oncostatic agent in cell models and in vivo studies.
Ma Z; Zhang X; Xu L; Liu D; Di S; Li W; Zhang J; Zhang H; Li X; Han J; Yan X
Pharmacol Res; 2019 Jul; 145():104265. PubMed ID: 31078746
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Versatility of Resveratrol Derivatives.
Nawaz W; Zhou Z; Deng S; Ma X; Ma X; Li C; Shu X
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29109374
[TBL] [Abstract][Full Text] [Related]
16. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
17. The resveratrol analogue trimethoxystilbene inhibits cancer cell growth by inducing multipolar cell mitosis.
Traversi G; Fiore M; Percario Z; Degrassi F; Cozzi R
Mol Carcinog; 2017 Mar; 56(3):1117-1126. PubMed ID: 27739192
[TBL] [Abstract][Full Text] [Related]
18. The resveratrol analogue, 3,4,5,4'‑trans-tetramethoxystilbene, inhibits the growth of A375 melanoma cells through multiple anticancer modes of action.
Androutsopoulos VP; Fragiadaki I; Spandidos DA; Tosca A
Int J Oncol; 2016 Oct; 49(4):1305-14. PubMed ID: 27498704
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene.
Belleri M; Ribatti D; Nicoli S; Cotelli F; Forti L; Vannini V; Stivala LA; Presta M
Mol Pharmacol; 2005 May; 67(5):1451-9. PubMed ID: 15703378
[TBL] [Abstract][Full Text] [Related]
20. 4,4'-Dihydroxy-trans-stilbene, a resveratrol analogue, exhibited enhanced antioxidant activity and cytotoxicity.
Fan GJ; Liu XD; Qian YP; Shang YJ; Li XZ; Dai F; Fang JG; Jin XL; Zhou B
Bioorg Med Chem; 2009 Mar; 17(6):2360-5. PubMed ID: 19251420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
